Iron regulation of chronic Toxoplasma gondii infection and immunity

NIH RePORTER · NIH · R21 · $193,935 · view on reporter.nih.gov ↗

Abstract

Toxoplasma gondii (Toxoplasma) causes an acute infection characterized by replicating tachyzoites that eventually develops into a chronic infection characterized by persisting bradyzoite stage Toxoplasma cysts in the brain and central nervous system. Chronic Toxoplasma infection affects ~30% of the United States population and during immune deficiency cysts reactivate and cause a severe Toxoplasmic encephalitis. There are currently no drugs or therapies that are effective at preventing cyst development or eliminating cysts in chronically infected individuals. The biology underpinning Toxoplasma cyst development, reactivation, and host immune control of acute and chronic infection is still poorly understood. From current evidence and preliminary data, we hypothesize that iron availability regulates parasite differentiation, cyst reactivation, and the effectiveness of the CD8+ T cell immune response in controlling acute infection and in preventing cyst reactivation. In Aim 1 we will investigate the role of iron sensing by the Toxoplasma Iron Regulatory Protein in differentiation and cyst reactivation. In Aim 2 we will investigate the role of iron availability in the development of CD8+ T cell mediated immunity and in the control of chronic cysts by CD8+ T cells. These two specific aims will test our novel hypothesis that iron regulates parasite stage differentiation and host immunity to acute and chronic infection. These high impact experiments are expected to define key iron regulated mechanisms that act on the parasite as well as the host to control differentiation, reactivation, and host immune control of infection. These studies address significant current gaps in knowledge that are major barriers to progress in the field.

Key facts

NIH application ID
10233427
Project number
1R21AI161298-01
Recipient
UNIVERSITY OF WYOMING
Principal Investigator
DAVID J BZIK
Activity code
R21
Funding institute
NIH
Fiscal year
2021
Award amount
$193,935
Award type
1
Project period
2021-03-02 → 2023-03-31